Especially after a certain age, it would be advisable to make medical supervision a healthy habit to be carried out over time. In fact, this not only serves to monitor current health levels, but also to prevent and ward off future diseases. In fact, in the course of the article we will talk about the studies that are working to identify biomarkers of diseases considered so far unpredictable. Specifically, we will go into the fight against degenerative diseases, such as Alzheimer’s and dementia, through specific analyzes useful for early diagnosis. The Alzheimer’s Research Center in Perth, Australia, reveals that a particular protein may be symptomatic of the onset of Alzheimer’s. In fact, not the shaky memory but this spy could announce Alzheimer’s as early as 20 years in advance.
Why prevention?
Estimates from the Ministry of Health predict an increase of three times the number of neurodegenerative diseases in the next thirty years, together with the growing average age.
In fact, according to estimates, a proportion of 280 elderly people for every 100 young people is expected in 2051, with a consequent increase in age-related diseases. However, control is always important because already after the age of 45, beware of this condition that opens the door to dementia and Alzheimer’s.
Not the shaky memory but this spy could announce Alzheimer’s as early as 20 years in advance
The study evaluates whether by simple blood tests it is possible to intercept the signals of certain disorders. The research involved 100 different subjects who had no Alzheimer’s symptoms and their levels of the Gfap protein were assessed. Glia acid fibrillar protein (Gfap) is naturally present in the brain but traces of it appear in the blood when it is affected by Alzheimer’s. The presence of Gfap coincides with the increase of beta amyloid, the substance of which senile plaques are made which, deposited on the brain, kill it. The study found that the increase of Gfap in plasma corresponds to the increase of beta amyloid in the brain already 20-30 years in advance. This would give the possibility to implement treatment and prevention therapies several decades earlier. A discovery that would also lead to the replacement of invasive and unpleasant controls such as lumbar punctures.
Overview
However, the Veronesi Foundation reports, although we are faced with the best early marker for Alzheimer’s, it is necessary to wait and deepen the research. Treatments on beta amyloid already in the past have not yielded the desired results. In addition, however, nothing excludes that a cure in the very advanced preclinical phase has significant effects.
Deepening
Very few choose this little-known flour but it is a natural killer of bad cholesterol